Xenotransplantation and risk : regulating a developing biotechnology /
Fovargue, Sara, 1971-
Xenotransplantation and risk : regulating a developing biotechnology / Sara Fovargue. - Cambridge, U.K. ; New York, N.Y. : Cambridge University Press, 2012. - 1 online resource (xiii, 291 pages) - Cambridge law, medicine and ethics . - Cambridge law, medicine, and ethics. .
Includes bibliographical references and index.
Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future.
"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--
English.
9781139223522 (electronic bk.) 1139223526 (electronic bk.) 9781139026925 (electronic bk.) 1139026925 (electronic bk.) 1107223474 9781107223479 1280484772 9781280484773 9786613579751 6613579750 1139221817 9781139221818 1139220098 9781139220095
9786613579751
Xenografts.
Transplantation immunology.
Xenografts--Moral and ethical aspects.
Transplantation of organs, tissues, etc.
Transplantation, Heterologous
Transplantation, Heterologous--ethics
Transplantation, Heterologous--legislation & jurisprudence
Transplantation Immunology
Hétérogreffes.
Greffe (Chirurgie)--Immunologie.
Hétérogreffes--Aspect moral.
Greffe (Chirurgie)
LAW--Medical Law & Legislation.
Transplantation immunology.
Transplantation of organs, tissues, etc.
Xenografts.
Electronic books.
QD188.8 / .F58 2012eb
344.04/194
Xenotransplantation and risk : regulating a developing biotechnology / Sara Fovargue. - Cambridge, U.K. ; New York, N.Y. : Cambridge University Press, 2012. - 1 online resource (xiii, 291 pages) - Cambridge law, medicine and ethics . - Cambridge law, medicine, and ethics. .
Includes bibliographical references and index.
Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future.
"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--
English.
9781139223522 (electronic bk.) 1139223526 (electronic bk.) 9781139026925 (electronic bk.) 1139026925 (electronic bk.) 1107223474 9781107223479 1280484772 9781280484773 9786613579751 6613579750 1139221817 9781139221818 1139220098 9781139220095
9786613579751
Xenografts.
Transplantation immunology.
Xenografts--Moral and ethical aspects.
Transplantation of organs, tissues, etc.
Transplantation, Heterologous
Transplantation, Heterologous--ethics
Transplantation, Heterologous--legislation & jurisprudence
Transplantation Immunology
Hétérogreffes.
Greffe (Chirurgie)--Immunologie.
Hétérogreffes--Aspect moral.
Greffe (Chirurgie)
LAW--Medical Law & Legislation.
Transplantation immunology.
Transplantation of organs, tissues, etc.
Xenografts.
Electronic books.
QD188.8 / .F58 2012eb
344.04/194